DKK2 | Dickkopf WNT signaling pathway inhibitor 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
EFCC1 | EF-hand and coiled-coil domain containing 1 | | | | | | Tissue enhanced |
EMP2 | Epithelial membrane protein 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
ESYT3 | Extended synaptotagmin-like protein 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
FBN3 | Fibrillin 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
FIGF | C-fos induced growth factor (vascular endothelial growth factor D) | Cancer-related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FMO2 | Flavin containing monooxygenase 2 (non-functional) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
FOLR1 | Folate receptor 1 (adult) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GDF10 | Growth differentiation factor 10 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GGTLC3 | Gamma-glutamyltransferase light chain 3 | | | | | | Tissue enhanced |
GPR116 | G protein-coupled receptor 116 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPRC5A | G protein-coupled receptor, family C, group 5, member A | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPRIN2 | G protein regulated inducer of neurite outgrowth 2 | | | | | | Tissue enhanced |
GRAMD2 | GRAM domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HHIP | Hedgehog interacting protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HLA-DRB5 | Major histocompatibility complex, class II, DR beta 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
ICAM4 | Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
INMT | Indolethylamine N-methyltransferase | Enzymes
| | | | | Tissue enhanced |
INMT-FAM188B | INMT-FAM188B readthrough (NMD candidate) | | | | | | Tissue enhanced |
IRX2 | Iroquois homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
IRX3 | Iroquois homeobox 3 | Transcription factors
| | | | | Tissue enhanced |
IRX5 | Iroquois homeobox 5 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
KAL1 | Kallmann syndrome 1 sequence | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | | | | | | Tissue enhanced |
KLRG2 | Killer cell lectin-like receptor subfamily G, member 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
LGI3 | Leucine-rich repeat LGI family, member 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LRRC36 | Leucine rich repeat containing 36 | | | | | | Tissue enhanced |
MARCO | Macrophage receptor with collagenous structure | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MATN3 | Matrilin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
MSR1 | Macrophage scavenger receptor 1 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NCKAP5 | NCK-associated protein 5 | | | | | | Tissue enhanced |
NDNF | Neuron-derived neurotrophic factor | Predicted secreted proteins
| | | | | Tissue enhanced |
NINJ2 | Ninjurin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
NKD2 | Naked cuticle homolog 2 (Drosophila) | | | | | | Tissue enhanced |
OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
OSCAR | Osteoclast associated, immunoglobulin-like receptor | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OVCH1 | Ovochymase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PCDHA12 | Protocadherin alpha 12 | Predicted membrane proteins
| | | | | Tissue enhanced |
PCSK9 | Proprotein convertase subtilisin/kexin type 9 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PEBP4 | Phosphatidylethanolamine-binding protein 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PRX | Periaxin | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
RAMP3 | Receptor (G protein-coupled) activity modifying protein 3 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
RS1 | Retinoschisin 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
RSPO4 | R-spondin 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
S100A3 | S100 calcium binding protein A3 | | | | | | Tissue enhanced |
SEC14L3 | SEC14-like 3 (S. cerevisiae) | Predicted secreted proteins
| | | | | Tissue enhanced |
SEC14L6 | SEC14-like 6 (S. cerevisiae) | | | | | | Tissue enhanced |
SHROOM4 | Shroom family member 4 | Disease related genes
| | | | | Tissue enhanced |
SLC11A1 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC39A8 | Solute carrier family 39 (zinc transporter), member 8 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |